CD19 and cancer: 3.1. Significantly Decreased CD19+ and Increased CD14+ Cells in Cancer Patients’ PBMCs; Decreased IFN-γ, GM-CSF, IL-1β, IL-7, IL-12, and IL-13 Secretion in Cancer Patients’ Peripheral-Blood Derived Sera